Chemotherapy-induced Thrombocytopenia clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
Hetrombopag Olamine Tablets Vs Placebo in Patients With Chemotherapy-Induced Thrombocytopenia (ExCIT)
open to eligible people ages 18 years and up
The ExCIT study is being conducted to evaluate the efficacy, and safety of of Hetrombopag Olamine Tablets Vs Placebo in Patients with Chemotherapy-Induced Thrombocytopenia.
at UCLA
Our lead scientists for Chemotherapy-induced Thrombocytopenia research studies include Wanxing Chai-Ho.
Last updated: